BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15166192)

  • 1. Commentary: hormones and heart disease: do trials and observational studies address different questions?
    Stampfer M
    Int J Epidemiol; 2004 Jun; 33(3):454-5. PubMed ID: 15166192
    [No Abstract]   [Full Text] [Related]  

  • 2. Commentary: the hormone replacement-coronary heart disease conundrum: is this the death of observational epidemiology?
    Lawlor DA; Davey Smith G; Ebrahim S
    Int J Epidemiol; 2004 Jun; 33(3):464-7. PubMed ID: 15166201
    [No Abstract]   [Full Text] [Related]  

  • 3. From presumed benefit to potential harm--hormone therapy and heart disease.
    Herrington DM; Howard TD
    N Engl J Med; 2003 Aug; 349(6):519-21. PubMed ID: 12904515
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hormonal replacement therapy and selective estrogen receptor modulators in prevention of cardiovascular disease].
    Kozakiewicz K; Wycisk A
    Wiad Lek; 2006; 59(5-6):377-82. PubMed ID: 17017486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New insights on the effects of hormone replacement therapy on the breast tissue and the orgnaism].
    Kubista E
    Wien Klin Wochenschr; 2003; 115 Suppl 2():46-9. PubMed ID: 15518146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone-replacement therapy and cardiovascular diseases.
    Bailar J
    N Engl J Med; 2003 Aug; 349(6):521-2. PubMed ID: 12904516
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial.
    Prentice RL; Langer R; Stefanick ML; Howard BV; Pettinger M; Anderson G; Barad D; Curb JD; Kotchen J; Kuller L; Limacher M; Wactawski-Wende J;
    Am J Epidemiol; 2005 Sep; 162(5):404-14. PubMed ID: 16033876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commentary: observation versus intervention--what's different?
    Barrett-Connor E
    Int J Epidemiol; 2004 Jun; 33(3):457-9. PubMed ID: 15166202
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hormone replacement therapy in menopause and cardiovascular disease--one more time].
    Os I; Tonstad S
    Tidsskr Nor Laegeforen; 2002 Aug; 122(18):1808-10. PubMed ID: 12362695
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hormone replacement therapy in menopause and cardiovascular disease].
    Pedersen AT; Skouby SO; Jespersen J; Ottesen BS
    Ugeskr Laeger; 2002 Aug; 164(34):3973-4. PubMed ID: 12212481
    [No Abstract]   [Full Text] [Related]  

  • 11. KEEPS: The Kronos Early Estrogen Prevention Study.
    Harman SM; Brinton EA; Cedars M; Lobo R; Manson JE; Merriam GR; Miller VM; Naftolin F; Santoro N
    Climacteric; 2005 Mar; 8(1):3-12. PubMed ID: 15804727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commentary: hazards of studying women: the oestrogen oestrogen/progesterone dilemma.
    Kuller LH
    Int J Epidemiol; 2004 Jun; 33(3):459-60. PubMed ID: 15166203
    [No Abstract]   [Full Text] [Related]  

  • 14. Hormone therapy and cardiovascular disease in the early postmenopause: the WHI data revisited.
    Pines A; Sturdee DW; Birkhäuser MH;
    Climacteric; 2007 Jun; 10(3):195-6. PubMed ID: 17487646
    [No Abstract]   [Full Text] [Related]  

  • 15. Health risks after cessation of postmenopausal hormone therapy.
    Pines A; Sturdee D; Birkhäuser M;
    Climacteric; 2008 Jun; 11(3):179-80. PubMed ID: 18568782
    [No Abstract]   [Full Text] [Related]  

  • 16. Appropriate use of hormones should alleviate concerns of cardiovascular and breast cancer risk.
    Lobo RA
    Maturitas; 2005 May; 51(1):98-109. PubMed ID: 15883114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
    Rosano GM; Vitale C; Fini M
    Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapy: the love affair is over (with response from Anna Fenton).
    Coney S
    N Z Med J; 2002 Sep; 115(1161):U162; discussion U162. PubMed ID: 12386669
    [No Abstract]   [Full Text] [Related]  

  • 19. What your doctor is reading. Hormone replacement therapy.
    Roberts SS
    Diabetes Self Manag; 2002; 19(6):78-81. PubMed ID: 12561772
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hormone replacement therapy and the risk of developing breast cancer].
    Merz WE
    MMW Fortschr Med; 2004 Feb; 146(9):26-8, 30. PubMed ID: 15352702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.